BrainChip: When will a big tech player take action?
Simon Ruic / 12.10.22 / 12:15
Shares in Australian start-up BrainChip (NYSE:BRAIN) are up 3.55% to AU$0.88 today after the company secured a new US patent for its super neuromorphic chip. Are the industry giants around Intel & Co. finally pricking their ears?
BrainChip Holding is an Australian technology company with solutions in the field of artificial intelligence and machine learning (AI & ML). The chip developer's flagship project is a so-called neuromorphic processor called Akida. It should come very close to how the brain works and therefore be very energy-efficient. The tech title is currently worth over US$ 900 million on the stock exchange.
The patent hunt continues
BrainChip's patent portfolio grows and grows. According to a stock market report on Wednesday, the manufacturer received another certificate of protection for the technology of its Akida processor from the US Patents & Trademarks Office.
According to BrainChip, the new patent entitled "An Improved Spiking Neural Network" increases the protection for its neuromorphic on-chip learning technology in particular. According to the report, memory management in BrainChip's flagship product is handled "innovatively", which would significantly reduce power consumption and costs when deploying edge applications to customers.
BrainChip now has 10 protection certificates in the USA and one in China. In addition, the company has now registered a total of 27 additional patents in the USA, Europe, Australia, Canada, Japan, Korea, India, Brazil, Russia, Mexico and Israel.
Is Selling Pressure Falling For The Stock?
Around the turn of the year, BrainChip caused a sensation in the industry for the first time by commercializing the world's first neuromorphic AI chips and possibly securing very promising patents.
Within three weeks, the processor developer's stock shot up by +200% to over AU$ 2.20. By March, however, most of the gains had evaporated. The already abysmal stock market environment for small tech stocks continued to deteriorate as a result of rising interest rates and fears of recession, and the paper subsequently fluctuated around the AU$ 1 mark with swings of up to 30%.
However, the pressure on Brain Chip stock from macroeconomic developments may now be easing. The Reserve Bank of Australia has already apparently slowed the pace of its tightening policy by raising interest rates by less than expected last Tuesday.
Significant partner network
In addition to the fact that BrainChip collects patents like other companies, the Australians have also maintained a positive flow of news with spectacular partnerships.
In the summer, the processor developer initially announced that it had been included in the industry giant ARM's AI Partner Program; A little later, the Akida makers officially launched their University AI Accelerator Program at five well-known US universities with AI institutes - including Carnegie Mellon University, which according to the magazine U.S. News & World Report has the best AI degree in the country, beating elite tech universities MIT and Stanford.
BrainChip had previously forged sales and research alliances in Europe and set further exclamation points: Heavyweights such as Mercedes and the US Air Force have announced a partnership with the Australians.
The buyout bet
However, anyone with a little knowledge of the industry knows that given the billions that tech giants spend on R&D every year, a real technological breakthrough for a small start-up is very unlikely.
In this respect, it makes me suspicious that apparently no big player has yet seriously considered taking over BrainChip. Risk-averse investors can still bet with a small portfolio share that a chip giant will give them a mega return with a buyout of the edge AI specialist.
Die Aktie des australischen Start-ups BrainChip (WKN: A14Z7W) klettert heute um +3,55% auf 0,88 AU$, nachdem sich das Unternehmen ein neues ...
www.sharedeals.de